Bone Density Tests & Bone Cancer: What You Need to Know

A bone density test (DXA scan) measures bone mineral density to assess osteoporosis risk—it is not a cancer screening tool.

Why DXA Doesn't Detect Bone Cancer

• Measures density, not cellular architecture or malignancy.
• Cancer may cause density changes, but these overlap with osteoporosis, fractures, metastases, Paget's disease, etc.
• Not sensitive or specific for primary bone tumors (osteosarcoma, Ewing sarcoma) or metastases.

When Bone Cancer Is Suspected

Symptoms warranting further workup:

• Persistent, worsening bone pain (often night pain)
• Swelling or palpable mass
• Pathological fracture (break from minor trauma)
• Unexplained weight loss, fatigue

Diagnostic Tests for Bone Cancer

• X-ray: Initial imaging; shows lytic/sclerotic lesions, periosteal reaction.
• MRI: Gold standard for local extent, soft tissue involvement.
• CT: Chest/abdomen/pelvis for staging/metastases.
• Bone scan (scintigraphy): Whole-body screening for multiple lesions.
• PET-CT: Metabolic activity assessment.
• Biopsy: Definitive diagnosis (core needle or open).

Takeaway: DXA assesses fracture risk. If you have bone pain or risk factors for bone cancer, ask your doctor about targeted imaging.